Abstract
The chemotactic responsiveness of blood monocytes was tested in 16 patients with nonseminomatous testicular carcinoma before, during, and after chemotherapy. All the patients initially had monocyte chemotaxis within the normal range. No correlation with the histology of the tumor, the clinical stage, or the presence in serum of α-fetoprotein and human chorionic gonadotropin was observed. Plasma from the patients did not inhibit the chemotaxis of normal monocytes, and serum from the patients contained no chemotactic factor inhibitor. During intensive chemotherapy with cis-platinum, bleomycin, and vinblastine a reversible defect in chemotaxis occurred without correlation to the development of fever. Two months after the completion of chemotherapy the chemotactic responsiveness was unchanged compared with pretreatment values. In conclusion, this study shows normal monocyte chemotaxis in patients with testicular carcinoma, which is in contrast to reports on a variety of other solid tumors.
Keywords: Carcinoma, Cancer Research, Solid Tumor, Clinical Stage, Bleomycin
References
- 1.Bandmann U, Norberg B, Rydgren L. Polymorphonuclear leucocyte chemotaxis in Boyden chambers: Effect of low concentrations of vinblastine. Scand J Haematol. 1974;13:305. doi: 10.1111/j.1600-0609.1974.tb00274.x. [DOI] [PubMed] [Google Scholar]
- 2.Boetcher DA, Leonard ES. Abnormal monocyte chemotactic response in cancer patients. J Natl Cancer Inst. 1974;52:1091. doi: 10.1093/jnci/52.4.1091. [DOI] [PubMed] [Google Scholar]
- 3.Böyum AJ (1969) Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21:[Suppl 97] [PubMed]
- 4.Crispe IN. The effect of vinblastine, colchicine and hexylene glycol on migration of human monocytes. Exp Cell Res. 1976;100:443. doi: 10.1016/0014-4827(76)90178-6. [DOI] [PubMed] [Google Scholar]
- 5.Edelson JP, Fudenberg HF. Effect of vinblastine on the chemotactic responsiveness of normal human neutrophils. Infect Immun. 1973;8:127. doi: 10.1128/iai.8.1.127-129.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Israël L, Samak R, Edelstein R. Defective monocyte killing in cancer patients. Lancet. 1980;II:1311. doi: 10.1016/s0140-6736(80)92385-5. [DOI] [PubMed] [Google Scholar]
- 7.Hausman MS, Brosman S, Snyderman R, Mickey MR, Fahey J. Defective monocyte function in patients with genitourinary carcinoma. J Natl Cancer Inst. 1975;55:1047. doi: 10.1093/jnci/55.5.1047. [DOI] [PubMed] [Google Scholar]
- 8.Kjeldsberg CR, Pay GD. A qualitative and quantitative study of monocytes in patients with malignant solid tumors. Cancer. 1978;41:2236. doi: 10.1002/1097-0142(197806)41:6<2236::aid-cncr2820410624>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
- 9.Kleinerman ES, Houser D, Young RC, Bull J, Zwelling LA, Barlock A, Decker JM, Muchmore AW. Defective monocyte killing in patients with malignancies and restoration of function during chemotherapy. Lancet. 1980;II:1102. doi: 10.1016/s0140-6736(80)92540-4. [DOI] [PubMed] [Google Scholar]
- 10.Kleinerman ES, Zwelling LA, Muchmore AW. Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminodichloroplatinum-(II) Cancer Res. 1980;40:3099. [PubMed] [Google Scholar]
- 11.Kleinerman ES, Zwelling LA. The effect of cis-diamminodichloroplatinum (II) on immune function in vitro and in vivo. Cancer Immunol Immunother. 1982;12:191. [Google Scholar]
- 12.Lauder I, Ahorne W, Stewart J, Salisbury R. Macrophage infiltration of breast tumors: a prospective study. J Clin Pathol. 1977;30:563. doi: 10.1136/jcp.30.6.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Nielsen H, Olesen Larsen S. Human monocyte chemotaxis in vitro. Influence of in vitro variables in the filter assay. Acta Pathol Microbiol Immunol Scand [C] 1983;91:109. [PubMed] [Google Scholar]
- 14.Nielsen H, Bennedsen J, Dombernowsky P. Normalization of defective monocyte chemotaxis during chemotherapy in patients with small cell anaplastic carcinoma of the lung. Cancer Immunol Immunother. 1982;14:13. doi: 10.1007/BF00199426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Nielsen H, Bennedsen J, Olesen Larsen S, Dombernowsky P, Viskum K. A quantitative and qualitative study of blood monocytes in patients with bronchogenic carcinoma. Cancer Immunol Immunother. 1982;13:93. doi: 10.1007/BF00205307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Nielsen H, Blom J, Olesen Larsen S. Human blood monocyte function in relation to age. Acta Pathol Microbiol Immunol Scand [C] 1984;92:5. doi: 10.1111/j.1699-0463.1984.tb00045.x. [DOI] [PubMed] [Google Scholar]
- 17.Norris DA, Weston WL, Sams M. The effect of immunosuppressive and anti-inflammatory drugs on monocyte function in vitro. J Lab Clin Med. 1977;90:569. [PubMed] [Google Scholar]
- 18.Rinehart JJ, Lange P, Gormus BJ, Kaplan ME. Human monocyte-induced tumor cell cytotoxicity. Blood. 1978;52:211. [PubMed] [Google Scholar]
- 19.Simmingskoeld G, Bandmann U, Norberg B. Mononuclear leucocyte chemotaxis in Boyden chambers: Inhibition by subantimitotic concentrations of antitubulin. Scand J Immunol. 1978;7:233. doi: 10.1111/j.1365-3083.1978.tb00449.x. [DOI] [PubMed] [Google Scholar]
- 20.Snyderman R, Seigler HF, Meadows L. Abnormalities of monocyte chemotaxis in patients with melanoma: Effects of immunotherapy and tumor removal. J Natl Cancer Inst. 1977;58:37. doi: 10.1093/jnci/58.1.37. [DOI] [PubMed] [Google Scholar]
- 21.Snyderman R, Meadows L, Holder W, Well S. Abnormal monocyte chemotaxis in patients with breast cancer: Evidence for a tumor-mediated effect. J Natl Cancer Inst. 1978;60:737. doi: 10.1093/jnci/60.4.737. [DOI] [PubMed] [Google Scholar]
- 22.Yam LT, Li CY, Crosby WH. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971;55:283. doi: 10.1093/ajcp/55.3.283. [DOI] [PubMed] [Google Scholar]